TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT
The advances in molecular biology have had a considerable influence on the medicinal treatment of patients with small cell lung cancer (NSCLC). The discovery of targets and development of drugs for molecular-targeted action improved the results of therapy of a specific group of patients. Translocati...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | Russian |
| 出版事項: |
Remedium Group LLC
2017-06-01
|
| シリーズ: | Медицинский совет |
| 主題: | |
| オンライン･アクセス: | https://www.med-sovet.pro/jour/article/view/1886 |